![Frontiers | Immunoglobulin Light Chain Gene Rearrangements, Receptor Editing and the Development of a Self-Tolerant Antibody Repertoire Frontiers | Immunoglobulin Light Chain Gene Rearrangements, Receptor Editing and the Development of a Self-Tolerant Antibody Repertoire](https://www.frontiersin.org/files/Articles/408358/fimmu-09-02249-HTML/image_m/fimmu-09-02249-g003.jpg)
Frontiers | Immunoglobulin Light Chain Gene Rearrangements, Receptor Editing and the Development of a Self-Tolerant Antibody Repertoire
![Emerging Therapeutics for the Treatment of Light Chain and Transthyretin Amyloidosis | JACC: Basic to Translational Science Emerging Therapeutics for the Treatment of Light Chain and Transthyretin Amyloidosis | JACC: Basic to Translational Science](https://www.jacc.org/cms/asset/5c177deb-f8f1-47d2-9888-ab4a84bd03fe/fx1.jpg)
Emerging Therapeutics for the Treatment of Light Chain and Transthyretin Amyloidosis | JACC: Basic to Translational Science
![Frontiers | Immunoglobulin Light Chain Gene Rearrangements, Receptor Editing and the Development of a Self-Tolerant Antibody Repertoire Frontiers | Immunoglobulin Light Chain Gene Rearrangements, Receptor Editing and the Development of a Self-Tolerant Antibody Repertoire](https://www.frontiersin.org/files/Articles/408358/fimmu-09-02249-HTML/image_m/fimmu-09-02249-g002.jpg)
Frontiers | Immunoglobulin Light Chain Gene Rearrangements, Receptor Editing and the Development of a Self-Tolerant Antibody Repertoire
![Immunoglobulin light chain amyloid aggregation - Chemical Communications (RSC Publishing) DOI:10.1039/C8CC04396E Immunoglobulin light chain amyloid aggregation - Chemical Communications (RSC Publishing) DOI:10.1039/C8CC04396E](https://pubs.rsc.org/image/article/2018/CC/c8cc04396e/c8cc04396e-f2_hi-res.gif)
Immunoglobulin light chain amyloid aggregation - Chemical Communications (RSC Publishing) DOI:10.1039/C8CC04396E
![Antibodies | Free Full-Text | Antibody Structure and Function: The Basis for Engineering Therapeutics Antibodies | Free Full-Text | Antibody Structure and Function: The Basis for Engineering Therapeutics](https://pub.mdpi-res.com/antibodies/antibodies-08-00055/article_deploy/html/images/antibodies-08-00055-g001.png?1577720963)
Antibodies | Free Full-Text | Antibody Structure and Function: The Basis for Engineering Therapeutics
![Genetic pathogenesis of immunoglobulin light chain amyloidosis: basic characteristics and clinical applications | Experimental Hematology & Oncology | Full Text Genetic pathogenesis of immunoglobulin light chain amyloidosis: basic characteristics and clinical applications | Experimental Hematology & Oncology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40164-021-00236-z/MediaObjects/40164_2021_236_Fig1_HTML.png)
Genetic pathogenesis of immunoglobulin light chain amyloidosis: basic characteristics and clinical applications | Experimental Hematology & Oncology | Full Text
![The pathogenesis of renal injury and treatment in light chain deposition disease | Journal of Translational Medicine | Full Text The pathogenesis of renal injury and treatment in light chain deposition disease | Journal of Translational Medicine | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12967-019-02147-4/MediaObjects/12967_2019_2147_Fig1_HTML.png)
The pathogenesis of renal injury and treatment in light chain deposition disease | Journal of Translational Medicine | Full Text
![Frontiers | Serum Free Immunoglobulins Light Chains: A Common Feature of Common Variable Immunodeficiency? Frontiers | Serum Free Immunoglobulins Light Chains: A Common Feature of Common Variable Immunodeficiency?](https://www.frontiersin.org/files/Articles/561146/fimmu-11-02004-HTML/image_m/fimmu-11-02004-g001.jpg)
Frontiers | Serum Free Immunoglobulins Light Chains: A Common Feature of Common Variable Immunodeficiency?
![Fatal amyloid formation in a patient's antibody light chain is caused by a single point mutation | eLife Fatal amyloid formation in a patient's antibody light chain is caused by a single point mutation | eLife](https://iiif.elifesciences.org/lax/52300%2Felife-52300-fig1-v1.tif/full/,1500/0/default.jpg)
Fatal amyloid formation in a patient's antibody light chain is caused by a single point mutation | eLife
![Biochemical and biophysical characterisation of immunoglobulin free light chains derived from an initially unbiased population of patients with light chain disease [PeerJ] Biochemical and biophysical characterisation of immunoglobulin free light chains derived from an initially unbiased population of patients with light chain disease [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2020/8771/1/fig-4-2x.jpg)
Biochemical and biophysical characterisation of immunoglobulin free light chains derived from an initially unbiased population of patients with light chain disease [PeerJ]
![Fatal amyloid formation in a patient's antibody light chain is caused by a single point mutation | eLife Fatal amyloid formation in a patient's antibody light chain is caused by a single point mutation | eLife](https://iiif.elifesciences.org/lax/52300%2Felife-52300-fig2-v1.tif/full/1500,/0/default.jpg)